Free Trial
ASX:OSP

Osprey Medical (OSP) Stock Price, News & Analysis

Osprey Medical logo

About Osprey Medical Stock (ASX:OSP)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.25 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Osprey Medical, Inc., a commercial stage company, provides contrast reduction and monitoring technologies in the United States and internationally. It offers DyeVert Plus EZ and DyeVert Power XT, and DyeVert Plus Systems, which are used to protect patients from the harmful effects of X-ray dye used during commonly performed angiographic imaging procedures. The company was incorporated in 2005 and is headquartered in Minnetonka, Minnesota.

Receive OSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Osprey Medical and its competitors with MarketBeat's FREE daily newsletter.

OSP Stock News Headlines

Trump Quietly Planning $15 Trillion Crypto Shocker
Most investors are still unaware, but I believe a new White House action may have quietly opened the floodgates for a $15 trillion crypto surge. My latest crypto playbook reveals the coin I’m most bullish on—including the name, ticker, and why I’m investing personal capital into it.
LivaNova announces OSPREY clinical study meets safety/efficacy endpoints
See More Headlines

OSP Stock Analysis - Frequently Asked Questions

Osprey Medical, Inc. (ASX:OSP) released its earnings results on Wednesday, August, 14th. The company reported ($0.04) earnings per share (EPS) for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Osprey Medical investors own include Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO), DW8 (DW8) and Dacian Gold (DCN).

Company Calendar

Last Earnings
8/14/2019
Today
5/27/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:OSP
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.96 million
Price / Cash Flow
0.47
Book Value
A$0.20 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (ASX:OSP) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners